March 9, 2021
University of Cincinnati researchers have discovered that cooperation between two key genes drive cancer growth, spread and treatment resistance in one particularly aggressive type of breast cancer. The good news is, though, with this knowledge, they can continue to aim their targeted treatments at these genes, singularly and together, to stop breast cancer in its tracks.
February 25, 2022
University of Cincinnati researchers led by Jiajie Diao and Yujie Sun have developed a new pH probe and imaging technique to provide researchers more information when studying diseases like cancer and Alzheimer's.
September 30, 2021
University of Cincinnati researchers have joined a nationwide clinical trial exploring the effectiveness of personalized treatments for patients with acute myelogenous leukemia (AML), a cancer of the blood and bone marrow.
October 8, 2021
WCPO featured Dr. Lawrence Sobel and patient Debra Ocho to highlight UC Health's TMIST breast cancer screening clinical trial participation.
October 11, 2021
The University of Cincinnati is opening a new clinical trial looking to see how the combination of immunotherapy and transplant can improve patient outcomes.
October 25, 2021
The University of Cincinnati's Dr. Xiaoting Zhang has been awarded a patent for a novel RNA nanoparticle treatment for breast cancer.
December 7, 2021
The University of Cincinnati's Dr. Vladimir Bogdanov has been awarded a Catalyst Research Award to further investigate if a drug he and his team developed is effective in treating pancreatic cancer.
September 29, 2021
UC experts explain how public health guidelines like mask requirements affects anxiety levels among groups of people, including children, first responders and other front line workers.
November 19, 2021
University of Cincinnati College of Pharmacy researchers have engineered a probiotic bacteria designed to break down cancer cell walls to allow therapies easier access to shrink tumors.
February 2, 2022
The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.